Zhang, Huai; Rios, Rafael S.; Boursier, Jerome et al.
HEPATOCYTE APOPTOSIS FRAGMENT PRODUCT CYTOKERATIN-18 M30 AND NON-ALCOHOLIC STEATOHEPATITIS RISK PREDICTION: AN INTERNATIONAL REGISTRY STUDYGUT. Bd. 71. 2022 S. A79-A80
Gehrke, Nadine; Woerns, Marcus A.; Mann, Amrit et al.
Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failureCELL DEATH & DISEASE. Bd. 13. H. 5. 2022
Kreft, Andreas; Schulze, Lisa; Ries, Isabelle et al.
Histological diagnosis of acute graft-versus-host disease in different sites of the upper gastrointestinal tract with correlation to endoscopic findingsLEUKEMIA & LYMPHOMA. 2022
Gehrke, Nadine; Hofmann, Lea J.; Straub, Beate K. et al.
IL-1 RECEPTOR TYPE 1 (IL-1R1) SIGNALING IN HEPATOCYTES IS INVOLVED IN LIVER CANCER DEVELOPMENT FROM NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)HEPATOLOGY. Bd. 76. 2022 S. S1419-S1420
Gonzalez-Sanchez, Hilda Minerva; Baek, Jea-Hyun; Weinmann-Menke, Julia et al.
IL-34 and protein-tyrosine phosphatase receptor type-zeta-dependent mechanisms limit arthritis in miceLABORATORY INVESTIGATION. Bd. 102. H. 8. 2022 S. 846-858
Berger, Marcel; Matlach, Juliane; Pitz, Susanne et al.
Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye diseaseSCIENTIFIC REPORTS. Bd. 12. H. 1. 2022
Unterrainer, Marcus; Deroose, Christophe M.; Herrmann, Ken et al.
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendationEUROPEAN JOURNAL OF CANCER. Bd. 176. 2022 S. 193-206
Hoegner, Anica; Moehler, Markus
Immunotherapy in Gastric CancerCURRENT ONCOLOGY. Bd. 29. H. 3. 2022 S. 1559-1574
Troebs, Sven; Prochaska, Juergen H.; Stuermlinger, Anna et al.
Impact of Heart Failure and Chronic Kidney Disease on Clinical Outcome in Relation to Presence of Type-2 Diabetes Mellitus Results From the Population-Based Gutenberg Health StudyCIRCULATION. Bd. 146. 2022
Labenz, Christian; Kostev, Karel; Alqahtani, Saleh A. et al.
Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes MellitusEXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. Bd. 130. H. 03. 2022 S. 172-177